Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
Should federal government employees, including military commanders, be investing their retirement money in China? Some say no, and will try to stop it this week.
The House Select Committee on the CCP held a debate this week with opposing teams arguing for ways to restrict outbound investment to China, including going after Silicon Valley venture capital firms.
Big trouble in China as Washington increasingly warns American businesses to “stay at your own risks”.
Tariffs — and China risks — have helped U.S. reshore and led to more investments in production, shifting the decades old focus away from offshoring.
Some in the Senate want to ban China from government retirement funds. Wall Street thinks it’s their fiduciary duty to be in China, despite losing money.
In hearing on climate policies, leader John Kerry was taken to task over China solar and says climate does not trump human rights violations.
The Congressional-Executive Committee on China says Temu, and even Nike, likely benefit from forced labor. Why the Uyghur Forced Labor law is vulnerable.
The House Ways & Means Committee hears from farmers who still say that, despite free trade deals with Mexico and Canada, some products still blocked.
The U.S. has passed laws promoting the use of electric vehicles and battery manufacturing. But where will all the raw materials come from?
